Composition-Tunable Ultrasmall Manganese Ferrite Nanoparticles: Insights into their In Vivo T₁ Contrast Efficacy

Abstract

The development of a highly efficient, low-toxicity, ultrasmall ferrite nanoparticle-based T 1 contrast agent for high-resolution magnetic resonance imaging (MRI) is highly desirable. However, the correlations between the chemical compositions, in vitro T 1 relaxivities, in vivo nano-bio interactions and toxicities remain unclear, which has been a challenge in optimizing the in vivo T 1 contrast efficacy. Methods : Ultrasmall (3 nm) manganese ferrite nanoparticles (Mn x Fe 3-x O 4 ) with different doping concentrations of the manganese ions (x = 0.32, 0.37, 0.75, 1, 1.23 and 1.57) were used as a model system to investigate the composition-dependence of the in vivo T 1 contrast efficacy. The efficacy of liver-specific contrast-enhanced MRI was assessed through systematic multiple factor analysis, which included the in vitro T 1 relaxivity, in vivo MRI contrast enhancement, pharmacokinetic profiles (blood half-life time, biodistribution) and biosafety evaluations ( in vitro cytotoxicity testing, in vivo blood routine examination, in vivo blood biochemistry testing and H&E staining to examine the liver). Results : With increasing Mn doping, the T 1 relaxivities initially increased to their highest value of 10.35 mM -1 s -1 , which was obtained for Mn 0.75 Fe 2.25 O 4 , and then the values decreased to 7.64 m M -1 s -1 , which was obtained for the Mn 1.57 Fe 1.43 O 4 nanoparticles. Nearly linear increases in the in vivo MRI signals (ΔSNR) and biodistributions (accumulation in the liver) of the Mn x Fe 3-x O 4 nanoparticles were observed for increasing levels of Mn doping. However, both the in vitro and in vivo biosafety evaluations suggested that Mn x Fe 3-x O 4 nanoparticles with high Mn-doping levels (x > 1) can induce significant toxicity. Conclusion : The systematic multiple factor assessment indicated that the Mn x Fe 3-x O 4 (x = 0.75-1) nanoparticles were the optimal T 1 contrast agents with higher in vivo efficacies for liver-specific MRI than those of the other compositions of the Mn ...

Remote Control of Mechanical Forces via Mitochondrial‐Targeted Magnetic Nanospinners for Efficient Cancer Treatment

“…The MNPs were synthesized via the method of thermal decomposition . It was modified and functionalized step by step ( Figure A).…”

“…Over time, the internalized TPP‐MNPs could escape from lysosomes of cancer cells. The lysosomal escape capability of the TPP‐MNPs could be facilitated by the highly positive charges of multivalent amine groups and a “proton sponge effect” associated with PLL . The last step was the mitochondria targeting induced by the TPP under the high mitochondrial membrane potential ΔΨm …”

Magnetic iron oxide nanomaterials: A key player in cancer nanomedicine

“…Ultrasmall magnetite nanoparticles with diameters less than 5 nm are candidates for T 1 MRI due to their low magnetization induced by the strong surface spin‐canting effect. Doping Mn or Gd ions into the ultrasmall Fe 3 O 4 has been proved to be effective in improving T 1 MRI contrast by generating a fully spin‐canted structure 56,57 . In addition, assembling USIONs into nanoparticles with a diameter of 100 nm could effectively increase their tumor accumulation, thus enhancing the T 1 MRI contrast 58 .…”

Ultrasmall Manganese Ferrites as Multimodal Bioimaging Agents and Fenton/Haber-Weiss Catalysts

“…This is consistent with the literature and it was also confirmed with energy-dispersive X-ray spectroscopy ( Figure SI4). 2,4 . Binding Energy (eV)…”